. Author manuscript; available in PMC: 2019 Jun 1.

Published in final edited form as: Psychiatr Q. 2018 Jun;89(2):293–305. doi: 10.1007/s11126-017-9534-7

Table 4.

Changes in Outcomes from Baseline to Post-treatment (three-months) for Study Participants

Measure	Baseline	Post-treatment	Change (95% CI)	P value^a
SRAHP	62.63	76.63	14.00 (−10.3, 38.3)	.216
IMRS	2.38	3.69	1.31 (0.93, 1.69)	<.001
Q-LES-Q-SF	34.12	44.71	10.59 (−8.4, 29.6)	.229
Herth Hope Index	33.00	35.63	2.63 (−0.9, 6.2)	.123
SEMCD	4.65	6.04	1.39 (−0.7, 3.5)	.152
MOS Social Support	39.49	53.53	14.04 (−15.5, 43.6)	.298
Empowerment	2.36	2.18	−0.19 (−0.5, 0.2)	.232

Two-tailed, paired t-test used to assess statistical significance.

Note: MOS Social Support=The Medical Outcomes Study Social Support Survey; IMRS=Illness Management and Recovery Scale;

SRAHPS=Self-Rated Abilities for Health Practices Scale; Quality of Life Enjoyment and Satisfaction Questionnaire – Short Form= Q-LES-Q-SF; Self-Efficacy for Managing Chronic Disease Scale=SEMCD.